Search
Sonnet Biotherapeutics Holdings Inc
SONNAdd to Watchlist
1.260USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
8.92MMarket Cap
LossP/E TTM
Sonnet Biotherapeutics Holdings Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
1.00M
5268.84%
EPS(YoY)
-3.95
65.22%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Sonnet Biotherapeutics Holdings Inc?
According to Sonnet Biotherapeutics Holdings Inc's FY2025 earnings report, its total revenue reached 1.00M, with a year-on-year change of 5268.84.
What are the current assets of Sonnet Biotherapeutics Holdings Inc?
According to Sonnet Biotherapeutics Holdings Inc's FY2025 earnings report, its current assets were 14.34M, with a year-on-year change of 577.20.
What are the total assets of Sonnet Biotherapeutics Holdings Inc?
According to Sonnet Biotherapeutics Holdings Inc's FY2025 earnings report, its total assets of Sonnet Biotherapeutics Holdings Inc were 14.88M, with a year-on-year change of 437.15.
What are the total liabilities of Sonnet Biotherapeutics Holdings Inc?
According to Sonnet Biotherapeutics Holdings Inc's FY2025 earnings report, its total liabilities of Sonnet Biotherapeutics Holdings Inc were 4.10M, with a year-on-year change of 25.80.
What is the total equity of Sonnet Biotherapeutics Holdings Inc?
According to Sonnet Biotherapeutics Holdings Inc's FY2025 earnings report, its total equity of Sonnet Biotherapeutics Holdings Inc was 10.79M, with a year-on-year change of 2320.86.
What is the net financing of Sonnet Biotherapeutics Holdings Inc?
According to Sonnet Biotherapeutics Holdings Inc's FY2025 earnings report, its net financing of Sonnet Biotherapeutics Holdings Inc was 26.05M, with a year-on-year change of 301.04.
What is the Earnings Per Share (EPS) of Sonnet Biotherapeutics Holdings Inc?
According to Sonnet Biotherapeutics Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.95, with a year-on-year change of 65.22.
What is the net margin of Sonnet Biotherapeutics Holdings Inc?
According to Sonnet Biotherapeutics Holdings Inc's FY2025 earnings report, its net profit margin was -1601.15, with a year-on-year change of 95.99.
What is the operating profit of Sonnet Biotherapeutics Holdings Inc?
According to Sonnet Biotherapeutics Holdings Inc's FY2025 earnings report, its operating profit was -15.84M, with a year-on-year change of -33.71.